{"ticker": {"uuid": "1c8eafba-14d4-4ed8-9b7c-65a4cdf02ca9", "symbol": "4579", "name": "RaQualia Pharma Inc.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Malaysia gives nod to RaQualia's Tegoprazan for gastroesophageal reflux disease treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNclNtZ3BWbThQX3ZoaG8weUticUprd1lFMnJPMHhvSW1qb2hNaWtEMEMyMG9rSzF6TkVEREgtdExqRzZkUFljQWNRdGxuT0JlVURZcUc2RDhuTVp5U3M5U3ZRaGRIc25XYjkxM3BoNjFPVXgzTFRxVW9vdUFJN3hYMzZqaVgxMWgxUklLal9VQmZHZjRTYVBscDFDMHdPd3hDS2REUEJVQUZ6eGFfSDFCZGtvTVNpLUFWY21BeWpVRzVTNk1GRUJqczhDRWdXOTNjUjk3OUl3?oc=5", "source_name": "BioSpectrum Asia", "published_at": "2024-09-27T07:00:00+00:00", "published_display": "27 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Malaysia gives nod to RaQualia's Tegoprazan for gastroesophageal reflux disease treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNclNtZ3BWbThQX3ZoaG8weUticUprd1lFMnJPMHhvSW1qb2hNaWtEMEMyMG9rSzF6TkVEREgtdExqRzZkUFljQWNRdGxuT0JlVURZcUc2RDhuTVp5U3M5U3ZRaGRIc25XYjkxM3BoNjFPVXgzTFRxVW9vdUFJN3hYMzZqaVgxMWgxUklLal9VQmZHZjRTYVBscDFDMHdPd3hDS2REUEJVQUZ6eGFfSDFCZGtvTVNpLUFWY21BeWpVRzVTNk1GRUJqczhDRWdXOTNjUjk3OUl3?oc=5", "source_name": "BioSpectrum Asia", "published_at": "2024-09-27T07:00:00+00:00", "published_display": "27 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 77, "total_relevant": 1, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 1, "score": 50, "total": 1, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 72, "events": [{"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 491.0, "latest_week": "2026-07-10", "one_week_move": 2.1, "four_week_move": 7.0, "twelve_week_move": -42.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.088927, "market_dynamics_buy_signal": false, "relative_strength": -48.984842, "fair_value_gap": -21.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 43.9373, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.1% over one week, +7.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "BioSpectrum Asia", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "directly relevant article"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.1% over one week, +7.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Malaysia gives nod to RaQualia's Tegoprazan for gastroesophageal reflux disease treatment"}], "updated_at": "2026-07-17T00:23:15.371142+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}